WaNPRC Director Deborah Fuller and University of Washington Assistant Professor of Microbiology Patrick Mitchell team up in this article in The Conversation to explain how funding cuts affect medical breakthroughs.
They explain how the termination of hundreds of active research grants could mean fewer clinical trials, fewer new treatments and fewer lifesaving drugs. Labs will likely shut down, jobs will be lost, and the process of discovery will stall.